VIATRIS INC (VTRS)

Company Profile

Viatris, Inc. is a global healthcare company, which engages in the provision of access to medicines and sustainable operations. The company is headquartered in Canonsburg, Pennsylvania and currently employs 37,000 full-time employees. The firm's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. Its Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in mainland China, Taiwan and Hong Kong. The JANZ segment consists of its operations in Japan, Australia and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, as well as the Company’s ARV franchise. Its portfolio comprises over 1,400 approved molecules across a range of key therapeutic areas, including key brands and complex generics. The company operates around 40 manufacturing sites worldwide, which produce oral solid doses, injectables, complex dosage forms and active pharmaceutical ingredients. Its products include Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen Auto Injector, Fraxiparine and Yupelri.

Company Info

VIATRIS INC

1000 Mylan Boulevard

Canonsburg PENNSYLVANIA 15317

P: 17245141465

CEO: Michael Goettler

Employees: 37000

Website: https://www.viatris.com/en